Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español
NIDA Home > Publications > Addiction Science: From Molecules to Managed Care > Relapse

Addiction Science: From Molecules to Managed Care

Relapse
Click for larger image Description
Drug addiction is a chronic illness with relapse rates similar to those of hypertension, diabetes, and asthma.

But medications alone are not enough. Drug addiction, like other chronic diseases requires long-term treatment to help people get to a point where they can manage their recovery and regain their lives.

Relapse rates are similar for drug addiction & other chronic illnesses

Relapse rates for drug addiction are similar to those of other well-characterized chronic illnesses. This slide compares relapse rates for drug-addicted patients with those suffering from diabetes, hypertension, and asthma. Relapse is common and similar across these illnesses (as is adherence to medication). Thus, drug addiction should be treated like any other chronic illness, with relapse serving as a trigger for renewed intervention.

Addiction is similar to other chronic illnesses because:

Drug addiction resembles other chronic diseases in more ways than relapse rates. These include both biological and behavioral components that need to be addressed during treatment, an expectation of long-term recovery requiring repeated episodes of treatment and the added value of support programs in sustaining it.

Full recovery is a challenge, but it is possible...

People do recover from drug abuse and addiction. Research bears this out.

DAT recovery with prolonged abstinence from methamphetamine

Extended abstinence is predictive of sustained recovery. The odds of remaining abstinent rise if patients have been abstinent for 1 to 3 years. After 3 years, the recovery odds remain high and stable. Therefore, as with other chronic diseases, addiction requires an ongoing and active disease management strategy.

Treatment reduces drug use and recidivism

It takes time, but the brain can recover. This slide shows images of dopamine transporter (DAT) binding in three brains: (1) a healthy control (top); (2) a methamphetamine abuser one month after discontinuing drug abuse (middle); and (3) a methamphetamine abuser after 14 months of abstinence (bottom). The control brain shows a robust concentration of dopamine transporters in the striatum (red and yellow), while the methamphetamine abuser has a dramatic drop in DAT binding, even a month after drug abuse has stopped. Sustained abstinence, however, allows a near-full return of DAT binding to normal levels. Still, some of the behavioral effects of methamphetamine do not completely return to normal (not shown). This means that it can take a long time to recover from methamphetamine abuse, but recovery is possible.

In treating drug addiction... we need to keep our eye on the real target.

Drug abuse treatment works and brings about reductions not just in drug abuse, but also in criminal recidivism. A therapeutic community approach (CREST) was tested in prison and continued during participants’ transition back to the community. Among those who completed treatment and aftercare programs, 35% remained drug free, and 69% were not arrested within three years of release from incarceration. These reductions in turn yield significant cost savings and provide hope for families and communities devastated by addiction.

In treating drug addiction... we need to keep our eye on the real target.

Addiction treatment aims to help people achieve abstinence and become full participants in society. Ancillary support services, in addition to behavioral and pharmacological treatments, help to connect people to needed social, medical, and employment services, to get their lives back on track.

<< LAST INDEX NEXT >>
Presentation Contents
Introduction
What is Addiction?
Why do People Abuse Drugs?
Drug Use Changes the Brain
Prevention/Development
Genes, Environment, Comorbidity
Treatment
Relapse
HIV/AIDS
International Program & Conclusion
Download Presentation
[Powerpoint - 10.4 MB]

Here are some other NIDA-related sites which may be of interest. Click on any of the links below to view those sites.



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Archives


National Institutes of Health logo Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. The U.S. government's official web portal